NUVA

Q: What is the price of NuVasive (NUVA) today?

The price of NuVasive (NUVA) today is $ 0.00, with return of 0% compared to the last year. The price of NuVasive (NUVA) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of NuVasive (NUVA) and international markets.

Q: When does NuVasive (NUVA) pay dividends?

NuVasive (NUVA) did not distribute dividends in the last year.

Q: Is NuVasive (NUVA) worth it?

Currently, NuVasive (NUVA) is priced at $ 0.00, with a P/E of 73.92%, representing a deviation of 6,623% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy NuVasive (NUVA) stock?

Investing in stocks of NuVasive (NUVA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of NuVasive (NUVA) yield today?

The yield of NuVasive (NUVA) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of NuVasive (NUVA) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NuVasive Inc.

Price

$ -

return (12m)

0.00%

p/e

73.92

p/bv

2.36

DIVIDEND YIELD

0.00%

NUVA price

NUVA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment NUVA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NUVA

review the fundamentals of NuVasive shares

P/E

73.92

Sector: -4.36 Industry: -13.38

P/S (PSR)

1.72

Sector: 1.79 Industry: 2.90

P/BV

2.36

Sector: 2.09 Industry: 1.79

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

1.36%

Sector: -30.33% Industry: -67.81%

ROE

3.19%

Sector: -39.83% Industry: -59.34%

ROIC

Sector: -418.66% Industry: -484.72%

NET MARGIN

2.32%

Sector: -32.52% Industry: -43.03%

GROSS MARGIN

71.66%

Sector: 42.44% Industry: 41.46%

OPERATING MARGIN

7.42%

Sector: -27.49% Industry: -38.68%

EV/EBITDA

29.73

Sector: -2.68 Industry: -9.74

EV/EBIT

-30.30

Sector: -3.96 Industry: -11.20

PRICE-TO-ASSETS

1.01

Sector: 1.06 Industry: 1.14

BVPS

16.87

Sector: 3.44 Industry: 1.62

EPS

0.54

Sector: -1.07 Industry: -1.89

EQUITY-TO-ASSETS RATIO

0.43

Sector: 0.39 Industry: 0.32

LIABILITIES / ASSETS

0.43

Sector: 0.45 Industry: 0.36

CAGR REVENUE 5 YEARS

1.49%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF NuVasive ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals NUVA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NUVA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT NuVasive

NuVasive Inc.

Average Investor10 user rating

4.0 (0 people)

United States

29 years

Founded: 1997

2004

Time since IPO - 22 years

2.700

Employees

The Company NuVasive Inc. (United States), is listed on Nasdaq with a market value of $ 2.10 Billions, having an equity of $ 892.54 Millions.

With a total of 2.700 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 1.23 Billion, which generated a profit in the amount of $ 28.45 Millions.

As for its main indicators, the Company has a P/E ratio of 73.92, a P/BV ratio of 2.36 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker NUVA.

Market cap

$ 2.10 Billions

Net worth

$ 892.54 Millions

US$ 892,543,000.00

Assets

$ 2.09 Billions

US$ 2,089,550,000.00

Total Shares Outstanding

52.91 Millions

52,907,000

Average Daily Trading Volume

$ 859.08 Thousand

US$ 859,084.00

Sector

Health

Industry

Medical Supplies and Equipment

NUVA

NUVA revenue and profits

Financial Results NUVA

DRAG THE FRAME TO SEE MORE DATA

NUVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.49 20,94% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 270.02 --14,47% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.11 --43,31% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 177.83 --28,58% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 471.84 43,24% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 935.58 30,21% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 154.03 53,71% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34